Sign In
Buy BDX
$170.12
-0.0900 (-0.0529%)
At Close: Aug 04, 2026
BD's (BDX) Latest PFS Launch to Boost Production Efficiencies
06:22pm, Wednesday, 14'th Sep 2022 Zacks Investment Research
BD's (BDX) newest product offering is expected to set a new standard in performance for vaccine PFS with new and strict specifications for improved production efficiencies.
BD's (BDX) Latest PFS Launch to Boost Production Efficiencies
03:44pm, Wednesday, 14'th Sep 2022
BD's (BDX) newest product offering is expected to set a new standard in performance for vaccine PFS with new and strict specifications for improved production efficiencies.
Implied Volatility Surging for BD (BDX) Stock Options
12:32pm, Tuesday, 13'th Sep 2022 Zacks Investment Research
Investors need to pay close attention to BD (BDX) stock based on the movements in the options market lately.
Here's Why You Should Hold on to BD (BDX) Stock for Now
02:03pm, Tuesday, 06'th Sep 2022 Zacks Investment Research
Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and strategic deals.
The All-Weather ETF Portfolio For Retirement
04:03am, Tuesday, 06'th Sep 2022 Seeking Alpha
A successful retirement can be attained by following some very simple suggestions. Click here for our all-weather ETF portfolio for retirement.
BD Chases End-To-End Supply Chain Visibility
09:44am, Friday, 02'nd Sep 2022
BD had a supply chain risk management solution. It provided good visibility to their Tier 1 suppliers.
BD to Present at the Wells Fargo 2022 Healthcare Conference
04:15pm, Wednesday, 24'th Aug 2022
FRANKLIN LAKES, N.J. , Aug. 24, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Far
BD's (BDX) Latest Collaboration to Boost Patient Outcome
01:28pm, Thursday, 18'th Aug 2022 Zacks Investment Research
BD's (BDX) tie-up with Accelerate Diagnostics is expected to strengthen the fight to combat the global threat of antimicrobial resistance, thereby boosting patient care.
3 Top Dividend Kings to Buy for the Long Haul
01:10pm, Thursday, 18'th Aug 2022 The Motley Fool
You'll need to hold these stocks for many years to get the full benefit of their consistent dividend growth.
3 Top Dividend Kings to Buy for the Long Haul
09:10am, Thursday, 18'th Aug 2022
You'll need to hold these stocks for many years to get the full benefit of their consistent dividend growth.
5 Analysts Have This to Say About Becton, Dickinson
03:09pm, Tuesday, 16'th Aug 2022 Benzinga
Within the last quarter, Becton, Dickinson (NYSE:BDX) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
2
0
0
1
Last
Salesforce To $273? Plus This Analyst Boosts Price Target On Snowflake
02:19pm, Tuesday, 16'th Aug 2022 Benzinga
Morgan Stanley cut the price target on Salesforce, Inc. (NYSE: CRM) from $291 to $273. Salesforce shares fell 1.7% to trade at $187.83 on Tuesday.
Barclays boosted the price target for Snowflake Inc
BD (BDX) Ties Up With LabCorp to Boost Patient Outcome
02:00pm, Monday, 15'th Aug 2022 Zacks Investment Research
BD's (BDX) latest partnership is expected to provide life-changing treatments for cancer and other diseases, thereby improving patient care.
Zimmer Biomet (ZBH) Sees Business Recovery, Global Growth
01:29pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Zimmer Biomet (ZBH) revenues ride on continued execution along with strong COVID recovery across most markets.
7 Blue-Chip Stocks That Will Survive 2022
10:23am, Tuesday, 09'th Aug 2022
Buying high-quality blue-chip stocks in a bear market could be a solid path to generating lucrative long-term returns. Blue-chip stocks are typically large-cap businesses in the mature stage of their
